Rare diseases
Investigational molecules
Locations
Strada Blaga Lucian Nr 4, 300002 Timisoara, Romania
Cabinet Particular Policlinic Algomed S.R.L. in Timisoara, Romania specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Acute haemorrhagic ulcerative colitis, Chronic hepatitis B, and other specialisations. This site conducts important research.
At Cabinet Particular Policlinic Algomed S.R.L. in Timisoara, the Gastroenterology department is focused on clinical trials in Digestive System Diseases, especially ulcerative colitis and Crohn’s disease. The research is centered on testing new treatment options, comparing emerging therapies with existing care, and following patients over time to better understand long-term safety and effectiveness.
The site contributes to research on both short-term symptom improvement and longer-term disease management, with a strong emphasis on IBD care for patients with moderate to severe disease.
Clinical trials currently enrolling participants at this site.
A study testing XmAb942 compared to placebo in adults with moderate-to-severe active ulcerative colitis
RomaniaStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
RomaniaStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
RomaniaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
RomaniaA study of LY4268989 and mirikizumab in adults with moderately to severely active ulcerative colitis
RomaniaStudy on GS-1427 for Adults with Moderate to Severe Ulcerative Colitis
RomaniaStudy Comparing AVT16 and Vedolizumab for Adults with Moderate to Severe Ulcerative Colitis
RomaniaStudy on the Effectiveness and Safety of PB016 and Vedolizumab for Patients with Moderately to Severely Active Ulcerative Colitis
RomaniaA study to evaluate the long-term safety and effectiveness of balinatunfib in adults with Crohn's disease or ulcerative colitis
RomaniaStudy of SAR441566 compared to placebo for adults with moderate to severe Crohn's disease
RomaniaStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
RomaniaStudy on the Effectiveness and Safety of Risankizumab for Patients with Moderate to Severe Crohn's Disease
RomaniaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
